Bristol-Myers Squibb: Growth Story And Valuation Is Convincing (NYSE:BMY)
Published
In the past I have published articles about pharmaceutical companies on a regular basis and one of the recurring themes in these articles was the resilience in case of a recession – this is including recent articles about AbbVie Inc. (ABBV) as well as Amgen Inc. (AMGN). And it seems like the…
#abbv #amgeninc #amgn #atlantic #bmy #bristolmyerssquibb #greatfinancialcrisis #spy #gileadsciences #gild